C4 Therapeutics, Inc.CCCCNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-102.91M
↓ 29% vs avg
Percentile
P43
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-79.82M
Historical baseline
PeriodValueYoY Change
2025$-102.91M+0.4%
2024$-103.37M+15.3%
2023$-122.10M+1.8%
2022$-124.28M-54.9%
2021$-80.25M-36.4%
2020$-58.83M-85.6%
2019$-31.70M-109.7%
2018$-15.12M-